KCT-0809 ophthalmic solution

DRUG4 trials

Sponsors

Kissei Pharmaceutical Co., Ltd.

Conditions

Dry Eye SyndromesDry Eye With Sjögren's Syndrome

Phase 2

A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes

CompletedNCT01890941

Kissei Pharmaceutical Co., Ltd.Dry Eye Syndromes

Updated: 2015-10-19

Phase 3

An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

TerminatedNCT02503176

Kissei Pharmaceutical Co., Ltd.Dry Eye With Sjögren's Syndrome

Updated: 2018-03-05

A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

CompletedNCT02503189

Kissei Pharmaceutical Co., Ltd.Dry Eye With Sjögren's Syndrome

Updated: 2017-05-17

A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

CompletedNCT02503163

Kissei Pharmaceutical Co., Ltd.Dry Eye With Sjögren's Syndrome

Updated: 2017-11-17